Generex Biotechnology Corp. (GNBTQ)

Last Closing Price: --

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Generex Biotechnology Corp. (GNBTQ) had Net Income of $9.22M for the most recently reported fiscal quarter, ending 2021-04-30.

Figures for fiscal quarter ending 2021-04-30
Income Statement Financials
$0.02M
Net Income
$9.22M
$0.07M
$-0.05M
$6.38M
$-6.36M
$14.85M
$8.49M
$8.49M
$8.49M
$8.49M
$8.49M
$8.49M
$-6.36M
$-6.10M
114.61M
140.41M
$0.08
$-0.04
Balance Sheet Financials
$2.47M
$0.12M
$43.45M
$45.92M
$64.07M
$0.55M
$25.93M
$90.01M
$-44.08M
$-87.25M
$-44.08M
116.28M
Cash Flow Statement Financials
$-1.74M
--
$3.40M
$0.02M
$1.68M
$1.66M
$2.17M
--
--
Fundamental Metrics & Ratios
0.04
--
--
-0.01
-0.21
-218.89%
-30748.75%
-30748.75%
--
41001.85%
44564.14%
$-1.74M
--
--
--
0.00
0.28
0.40
227.46
-19.25%
-9.73%
18.48%
-19.49%
$-0.38
$-0.01
$-0.01